Literature DB >> 17589132

Werdnig Hoffman's disease (spinal muscular atrophy type I): A clinical study of 25 Saudi nationals in Al-Khobar.

S Al-Rajeh1, O Bademosi, G G Gascon, D Stumpf.   

Abstract

We describe the clinical features of 25 cases of Werdnig Hoffman's disease (spinal muscular atrophy (SMA) type I) seen propectively over a two-year period at the King Fahd Hospital of the University (KFHU), Al-Khobar. The hospital incidence rate was 1.93 per 1,000 live births (95% confidence limits, 0.80-3.06/1,000). The estimated prevalence rate for the community was 0.92/10,000 with 0.59-1.25 per 10,000 children as its 95% confidence limits. The male to female ratio was 2:3. Reduced fetal movements were reported by six mothers; 8 children (32%) had symptoms at birth, and 24 (96%) had symptoms by the time they were six months old. Other features apart from hypotonia, muscle weakness, and absent deep tendon reflexes included head lag with inability to achive head control at six months (88%), respiratory problems consisting of difficulty with breathing or frequent chest infections (44%), and difficulty with feeding (40%). Wasting with fisciculations of the tongue was seen in 64%. Death occurred within six months of presentation in 75% of the cases. The parents were consanguineous in 64% of the cases. This high consanguinity rate was probably the major cause for the high population prevalence rate.

Entities:  

Year:  1992        PMID: 17589132     DOI: 10.5144/0256-4947.1992.67

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  2 in total

1.  A homozygous double mutation in SMN1: a complicated genetic diagnosis of SMA.

Authors:  Susan M Kirwin; Kathy M B Vinette; Iris L Gonzalez; Hind Al Abdulwahed; Nouriya Al-Sannaa; Vicky L Funanage
Journal:  Mol Genet Genomic Med       Date:  2013-05-30       Impact factor: 2.183

2.  Gene therapy for spinal muscular atrophy: the Qatari experience.

Authors:  Hossamaldein Gaber Ali; Khalid Ibrahim; Mahmoud Fawzi Elsaid; Reem Babiker Mohamed; Mahmoud I A Abeidah; Azhar Othman Al Rawwas; Khaled Elshafey; Hajer Almulla; Karen El-Akouri; Mariam Almulla; Amna Othman; Sara Musa; Fatma Al-Mesaifri; Rehab Ali; Noora Shahbeck; Mariam Al-Mureikhi; Reem Alsulaiman; Saad Alkaabi; Tawfeg Ben-Omran
Journal:  Gene Ther       Date:  2021-07-19       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.